As of 2024-12-13, the Fair Value of Stayble Therapeutics AB (STABL.ST) is -2.33 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.50 SEK, the upside of Stayble Therapeutics AB is -568.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 5Y Avg | |
| Net income | -2.81 | -6.13 | -7.41 | -15.49 | -12.09 | -8.79 |
| YoY growth | -134.17% | -118.15% | -20.88% | -109.04% | 21.95% | -72.06% |
| Market Cap (mil) | 21.77 |
| P/E | |
| Forward P/E |
| EPS | -0.47 |
| Avg earnings growth rate | -72.06% |
| TTM earnings | -20.40 |